Skip to main content
Monsenso A/S logo

Monsenso A/S — Investor Relations & Filings

Ticker · MONSO ISIN · DK0061277977 LEI · 52990024UWU19T5URJ57 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 146 across all filing types
Latest filing 2026-04-14 Share Issue/Capital Cha…
Country DK Denmark
Listing ST MONSO

About Monsenso A/S

https://www.monsenso.com/

Monsenso A/S is a technology company that provides a digital health solution for mental healthcare and research. The solution connects individuals, clinicians, and carers to support the prevention, early intervention, and treatment of mental illnesses. The core product is a scalable, configurable platform that functions as a CE-marked Class 1 medical device. It consists of a patient-facing smartphone app that collects self-reported outcomes and objective data from sensors and wearables, and a web portal for clinicians to access this data for remote monitoring and personalized treatment. The platform supports a wide range of conditions, including depression, bipolar disorder, anxiety, and schizophrenia. Monsenso partners with healthcare providers, pharmaceutical companies, and researchers to facilitate remote care, support decentralized clinical trials, and gather real-world evidence.

Recent filings

Filing Released Lang Actions
Monsenso A/S rejser et bruttoprovenu på DKK 3,2 mio. gennem en rettet aktieemission
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement (“Selskabsmeddelelse”) reporting the results of a directed share issuance, detailing the number of new shares issued, subscription price, gross and net proceeds, share capital increase, and ISIN arrangement. This clearly fits the definition of a Share Issue/Capital Change announcement (SHA).
2026-04-14 Danish
Monsenso A/S søger at gennemføre en rettet aktieemission for at styrke selskabets likviditet og fremtidige vækstmuligheder
Share Issue/Capital Change Classification · 90% confidence The document is a company press release announcing a directed share issue (“rettet aktieemission”) without pre-emptive rights, detailing the number of new shares, subscription price, and share capital impact. This clearly falls under announcements of new share issues/capital changes.
2026-04-13 Danish
INDKALDELSE TIL ORDINÆR GENERALFORSAMLING
AGM Information Classification · 88% confidence The document is an appendix (“Bilag 1”) presenting biographies and current positions of board director candidates. This type of content is typically included as meeting materials for an Annual General Meeting (AGM) to inform shareholders about each nominee. It is not a vote result announcement, proxy statement text, nor a full report. Hence, it fits the AGM Information category (materials shared during the AGM).
2026-03-24 Danish
INDKALDELSE TIL ORDINÆR GENERALFORSAMLING
Proxy Solicitation & Information Statement Classification · 81% confidence The document is an official invitation (“indkaldelse”) to the company’s ordinary general meeting (AGM) and contains the agenda, full proposals, voting procedures, proxy and electronic voting instructions. It is sent to shareholders to provide information and to solicit their votes. This matches our definition of a Proxy Solicitation & Information Statement (PSI).
2026-03-24 Danish
Correction: Monsenso signs large commercial order with private, international healthcare provider
Regulatory Filings Classification · 95% confidence The document is a company announcement (Selskabsmeddelelse) regarding a new commercial contract win. It describes the nature of the contract, its impact on financial risk, and mentions future capital raising plans. Since it is a specific corporate announcement regarding business operations and contract wins that does not fit into specialized categories like M&A or dividend notices, it falls under the general regulatory announcement category.
2026-03-20 Danish
Correction: Monsenso signs large commercial order with private, international healthcare provider
Regulatory Filings Classification · 95% confidence The document is a short company announcement (2614 characters) regarding a new commercial contract and future capital raising plans. It is labeled as 'Inside information' and 'Company Announcement no. 02-2026'. It does not constitute a full financial report, presentation, or specific regulatory filing like a 10-K or IR. Since it is a general corporate announcement regarding business operations and inside information that does not fit into specific categories like M&A or share buybacks, it falls under the 'Regulatory Filings' (RNS) category.
2026-03-20 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.